|Benchmark Company||Bruce D. Jackson|
|Brookline Capital Markets||Kumaraguru Raja, PhD|
|Ladenburg Thalmann & Co.||Robert M. LeBoyer|
|Maxim Group||Jason McCarthy, PhD|
CNS Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding CNS Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of CNS Pharmaceuticals, Inc. or its management. CNS Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.